Emmessar Biotech & Nutrition share news and announcements
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹22.32.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹11 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Aug 2026
- 26.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Aug 2026
- −18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,899
Emmessar Biotech & Nutrition share news and announcements
536 announcements, routine notices left out, newest first. Page 5 of 11.
Feb 2021
Jan 2021
28 Jan · Board meeting
Meeting on 6 Feb 2021: quarterly results14 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....12 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 0 1
Dec 2020
Nov 2020
25 Nov · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on November 25, 2020 with reference to significant movement in price, in order to ensure that investors have ....
Oct 2020
28 Oct · Board meeting
Meeting on 6 Nov 2020: quarterly results14 Oct · Compliance Certificate For The Period Ended September 30, 2020
13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 08 Oct · Compliance Cert. U/R 40(9) Of SEBI[LODR] Regln., 2015 For The Half Year Ended September 30, 2020.
6 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....3 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2020
7 Sep · Reg. 34 (1) Annual Report
1 Sep · Board meeting
Meeting on 10 Sep 2020: quarterly results
Aug 2020
10 Aug · Disclosure Of Material Impact Of COVID-19 Pandemic On The Company.
Jul 2020
16 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 014 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....
Jun 2020
23 Jun · Board meeting
Meeting on 30 Jun 2020: audited results10 Jun · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....8 Jun · Attaching The Compliance Certificate U/R 40(9)
8 Jun · Compliance Certificate For The Period Ended March 31, 2020
5 Jun · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2020
Feb 2020
Jan 2020
8 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....6 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 03 Jan · Board meeting
Meeting on 7 Feb 2020: quarterly results
Dec 2019
Nov 2019